A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)

Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/29286

Title:	A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)
Authors:	Yurdaydın, Cihan Wedemeyer, Heiner Dalekos, George Erhardt, Alexander Çakaloğlu, Y. Değertekin, H. Zeuzem, Stefan Zachou, Kalliopi Bozkaya, Hakan Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Gastroenteroloji Bilim Dalı. Gürel, S.
Keywords:	Gastroenterology & hepatology
Issue Date:	Oct-2006
Publisher:	Wiley
Citation:	Yurdaydın, C. vd. (2006). ''A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)''. Hepatology, 44(4), Suplement 1, 230A-230A.
Description:	Bu çalışma, 27-31 Ekim 2006 tarihleri arasında Boston[Amerika Birleşik Devletleri]’da düzenlenen 57. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.
URI:	http://hdl.handle.net/11452/29286
ISSN:	0270-9139
Appears in Collections:	Web of Science

Files in This Item:

There are no files associated with this item.

DSpace JSPUI